Published in J Hepatol on November 09, 2005
Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98
Molecular targeted therapies in hepatocellular carcinoma. Hepatology (2008) 6.16
Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology (2010) 2.68
Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology (2013) 2.42
Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology (2011) 2.39
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol (2009) 2.22
Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology (2013) 2.13
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int (2008) 2.10
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol (2014) 2.01
Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites. Clin Gastroenterol Hepatol (2013) 1.72
A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J Hepatol (2014) 1.72
The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol (2009) 1.69
Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol (2008) 1.63
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology (2011) 1.63
Health-related quality of life and survival in liver transplant candidates. Liver Transpl (2010) 1.55
Declining liver graft quality threatens the future of liver transplantation in the United States. Liver Transpl (2015) 1.50
Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation. Liver Transpl (2014) 1.48
Underestimation of liver-related mortality in the United States. Gastroenterology (2013) 1.46
Thrombocytopenia and bleeding in veterans with non-hepatitis C-related chronic liver disease. Dig Dis Sci (2012) 1.42
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.33
Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int (2012) 1.29
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Gut Liver (2015) 1.23
Model for end-stage liver disease: end of the first decade. Clin Liver Dis (2011) 1.20
Role of magnetic resonance elastography in compensated and decompensated liver disease. J Hepatol (2013) 1.20
Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol (2014) 1.20
Cost-effectiveness of screening for hepatitis C in Canada. CMAJ (2015) 1.16
Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol (2013) 1.15
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol (2015) 1.14
Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol (2009) 1.14
Hepatitis C, stigma and cure. World J Gastroenterol (2013) 1.13
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology (2010) 1.12
Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci (2012) 1.12
Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology (2015) 1.11
Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ (2006) 1.10
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front Physiol (2012) 1.07
Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology (2011) 1.07
Transarterial Chemoembolization of Child-A hepatocellular carcinoma: drug-eluting bead TACE (DEB TACE) vs. TACE with cisplatin/lipiodol (cTACE). Med Sci Monit (2011) 1.06
Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol (2008) 1.06
Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol (2014) 1.03
Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol (2009) 1.01
Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol (2014) 1.00
Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 0.99
Correlation of serum liver fibrosis markers with severity of liver dysfunction in liver cirrhosis: a retrospective cross-sectional study. Int J Clin Exp Med (2015) 0.96
Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database. Clin Gastroenterol Hepatol (2015) 0.95
Hepatocellular carcinoma: a review. J Hepatocell Carcinoma (2016) 0.95
Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. PLoS One (2013) 0.93
Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg (2009) 0.93
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr (2013) 0.93
The impact of hepatic pressurization on liver shear wave speed estimates in constrained versus unconstrained conditions. Phys Med Biol (2011) 0.92
Organ allocation for chronic liver disease: model for end-stage liver disease and beyond. Curr Opin Gastroenterol (2010) 0.92
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis. Gastroenterology (2015) 0.92
Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis. Diabetes Metab J (2016) 0.92
Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open (2016) 0.91
Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion. Hepatol Int (2011) 0.91
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore) (2016) 0.90
Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials. Gastroenterol Res Pract (2015) 0.89
Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond. World J Gastroenterol (2014) 0.89
Socioeconomic status and survival of cirrhosis patients: a Danish nationwide cohort study. BMC Gastroenterol (2009) 0.89
Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update. World J Gastroenterol (2013) 0.89
Liver and spleen stiffness and their ratio assessed by real-time two dimensional-shear wave elastography in patients with liver fibrosis and cirrhosis due to chronic viral hepatitis. Eur Radiol (2015) 0.89
Liver Injury and the Activation of the Hepatic Myofibroblasts. Curr Pathobiol Rep (2013) 0.89
Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement. World J Hepatol (2015) 0.88
Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis. Dig Dis Sci (2016) 0.88
The accuracy of ultrasonography for the evaluation of portal hypertension in patients with cirrhosis: a systematic review. Korean J Radiol (2015) 0.88
Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol (2014) 0.87
Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors. Invest New Drugs (2015) 0.87
Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis. J Clin Gastroenterol (2015) 0.87
Acute-on-chronic liver failure: a review. Ther Clin Risk Manag (2014) 0.87
Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease. Clin Gastroenterol Hepatol (2016) 0.87
Non-invasive diagnosis of hepatitis B virus-related cirrhosis. World J Gastroenterol (2014) 0.87
Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clin Gastroenterol Hepatol (2015) 0.86
Bone marrow derived stem cells for the treatment of end-stage liver disease. World J Gastroenterol (2014) 0.86
Improving survival in decompensated cirrhosis. Int J Hepatol (2012) 0.86
Ascites in patients with cirrhosis. Can Fam Physician (2013) 0.86
Alcoholic Liver Disease: Update on the Role of Dietary Fat. Biomolecules (2016) 0.86
Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis. World J Hepatol (2014) 0.86
Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B. Gut Liver (2015) 0.86
Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology (2013) 0.85
Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol (2015) 0.85
Integration of palliative care in end-stage liver disease and liver transplantation. J Palliat Med (2014) 0.85
Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease. Clin Exp Gastroenterol (2014) 0.85
High mortality of pneumonia in cirrhotic patients with ascites. BMC Gastroenterol (2013) 0.85
Effect of temporal resolution on 4D flow MRI in the portal circulation. J Magn Reson Imaging (2013) 0.84
A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension. Liver Int (2009) 0.84
Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series. Alcohol Clin Exp Res (2010) 0.83
Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease. Int J Hepatol (2011) 0.83
Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study. Med Sci Monit (2015) 0.82
Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement. World J Hepatol (2015) 0.82
Cardiovascular determinants of survival in cirrhosis. Gut (2007) 0.82
Investigating the efficacy of subharmonic aided pressure estimation for portal vein pressures and portal hypertension monitoring. Ultrasound Med Biol (2012) 0.82
Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Hepat Med (2013) 0.82
Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Med Sci Monit (2012) 0.81
Host genetics predict clinical deterioration in HCV-related cirrhosis. PLoS One (2014) 0.81
Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis. PLoS One (2015) 0.81
Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis. PLoS One (2015) 0.81
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med (2005) 6.31
Vascular disorders of the liver. Hepatology (2009) 5.38
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology (2007) 4.09
Acute-on chronic liver failure. J Hepatol (2012) 3.74
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology (2002) 3.50
Bacterial translocation (BT) in cirrhosis. Hepatology (2005) 3.07
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology (2005) 2.91
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology (2008) 2.69
Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis (2008) 2.47
Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology (2003) 2.38
Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int (2010) 2.32
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol (2009) 2.22
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol (2010) 2.16
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int (2008) 2.10
Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology (2012) 2.01
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology (2014) 1.89
Recommendations for probiotic use--2008. J Clin Gastroenterol (2008) 1.76
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology (2011) 1.63
Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: a diagnostic accuracy study. Hepatology (2014) 1.60
Intensive care of the patient with cirrhosis. Hepatology (2011) 1.54
Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol (2005) 1.51
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1. Liver Transpl (2011) 1.44
The ethical problem of randomization. Intern Emerg Med (2014) 1.43
Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Am J Gastroenterol (2004) 1.43
Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment? Am J Gastroenterol (2002) 1.39
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol (2010) 1.36
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int (2012) 1.29
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology (2008) 1.24
Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology (2008) 1.21
Patients' preferences for treatment of hepatitis C. Med Decis Making (2009) 1.20
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16
High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol (2012) 1.15
Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol (2009) 1.14
Management of gastropathy and gastric vascular ectasia in portal hypertension. Clin Liver Dis (2010) 1.09
Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol (2007) 1.05
What do patients consider when making decisions about treatment for hepatitis C? Am J Med (2005) 1.03
The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis (2010) 1.02
Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol (2009) 1.01
Patients' experiences related to anti-viral treatment for hepatitis C. Patient Educ Couns (2005) 1.01
A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology (2008) 0.97
Multiple angiomyolipomata of the liver: a case report. Mod Pathol (2002) 0.97
Psychosocial issues in hepatitis C: a qualitative analysis. Psychosomatics (2009) 0.93
Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology (2012) 0.93
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
Classification of cirrhosis: the clinical use of HVPG measurements. Dis Markers (2011) 0.92
Acute kidney injury in patients with cirrhosis: perils and promise. Clin Gastroenterol Hepatol (2013) 0.92
Bevacizumab: finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia. Hepatology (2013) 0.89
Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients. Hepatology (2014) 0.88
Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients. AJR Am J Roentgenol (2006) 0.87
Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis. J Clin Gastroenterol (2015) 0.87
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Semin Liver Dis (2008) 0.86
Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection. Patient Prefer Adherence (2012) 0.86
Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients. Cochrane Database Syst Rev (2010) 0.85
Bacterial translocation up-regulates GTP-cyclohydrolase I in mesenteric vasculature of cirrhotic rats. Hepatology (2003) 0.85
Sildenafil has no effect on portal pressure but lowers arterial pressure in patients with compensated cirrhosis. Clin Gastroenterol Hepatol (2010) 0.84
Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr (2011) 0.84
Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology (2007) 0.84
Probiotics and liver disease. J Clin Gastroenterol (2008) 0.83
Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls. J Clin Gastroenterol (2013) 0.82
Familial occurrence of inflammatory bowel disease in celiac disease. Inflamm Bowel Dis (2003) 0.81
Managing varices: drugs, bands, and shunts. Gastroenterol Clin North Am (2011) 0.81
Hemolytic-uremic syndrome in a dog. Vet Clin Pathol (2005) 0.80
Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: and the winner is... Hepatology (2009) 0.80
A commonsense approach to esophageal varices. Clin Liver Dis (2006) 0.79
Hepatic arteriolosclerosis: a small-vessel complication of diabetes and hypertension. Am J Surg Pathol (2015) 0.79
Spontaneous bacterial peritonitis. Rev Gastroenterol Mex (2005) 0.78
Non-hemorrhagic acute complications associated with cirrhosis and portal hypertension. Best Pract Res Clin Gastroenterol (2013) 0.78
Ultrasonographic features of peritoneal cestodiasis caused by Mesocestoides sp. in a dog and in a cat. Vet Radiol Ultrasound (2005) 0.77
A decade of trials of interferon-alpha for chronic hepatitis C. A meta-regression analysis. Contemp Clin Trials (2005) 0.77
Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews. J Gastroenterol Hepatol (2011) 0.77
Examining Hepatitis C Virus Treatment Preference Heterogeneity Using Segmentation Analysis: Treat Now or Defer? J Clin Gastroenterol (2016) 0.77
Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. Ultrasound Q (2016) 0.76
Endoscopic variceal banding vs. pharmacological therapy for the prevention of recurrent variceal hemorrhage: what makes the difference? Gastroenterology (2002) 0.76
Meta-analysis of trials for variceal bleeding. Hepatology (2002) 0.76
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: in search of predictors of significant disease. Hepatology (2008) 0.75
Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study. J Clin Gastroenterol (2016) 0.75
Reply to: "Acute-on-chronic liver failure - its definition remains unclear". J Hepatol (2013) 0.75
Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension. Curr Treat Options Gastroenterol (2007) 0.75
The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis. Clin Gastroenterol Hepatol (2012) 0.75
MTHFR C677T homozygous as risk factor for complications after OLT for cryptogenic cirrhosis. Clin Transplant (2006) 0.75
Editorial: Clostridium difficile infection: Yet another predictor of poor outcome in cirrhosis. Am J Gastroenterol (2010) 0.75
Portal hypertension and hepatocellular carcinoma: prognosis and beyond. Clin Gastroenterol Hepatol (2006) 0.75
[Evidence-based medicine: a new paradigm for medicine and a brand for the megastore of medicinal literature]. Recenti Prog Med (2014) 0.75
[Individual response to treatment: from Withering to contemporary medicine]. Recenti Prog Med (2015) 0.75
Disseminated non-Hodgkin's lymphoma and chronic hepatitis C: a case report. Ann Ital Med Int (2004) 0.75
Reply to Risk Stratification in Acute Variceal Bleeding: Child-Pugh Versus Model for End-stage Liver Disease. J Clin Gastroenterol (2017) 0.75